Skip to content
    Broadview Ventures logo

    Broadview Ventures

    Boston, Massachusetts, United StatesFounded 2009

    Broadview Ventures is a mission-driven venture philanthropy organization created by the Leducq Charitable Trust, providing seed and early-stage equity funding to companies developing innovative technologies for the diagnosis and treatment of cardiovascular disease and stroke. Headquartered in Boston, it invests across therapeutics, devices, diagnostics, and digital health from pre-clinical through clinical proof-of-concept stages.

    49% of their portfolio is in Healthcare. Average disclosed round size is $22.2M (across 27 rounds with reported amounts).

    Find people at Broadview Ventures on Goldilocks AI

    Portfolio

    27

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    1

    Team

    DG

    Daniel Gottlieb, MBA

    Managing Director

    TN

    Thomas Needham, MBA

    Managing Director

    CD

    Christopher de Souza, PhD

    Director, Biopharma Team

    KK

    Kelly Krajnik, MBA

    Director, Head of MedTech

    NN

    Nichole Neal, MBA

    Director of Operations

    BK

    Benjamin Kreitman

    Principal, Biopharma Team

    DP

    David Prim, PhD

    Principal, Medtech Team

    HL

    Hewmun Lau, MBA

    Principal, Biopharma Team

    KM

    Khushbu Modi

    Executive Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    37 investments
    CompanyRoundAmountDate
    Atacor logoAtacorGrowth$75MOct 2025
    Mosanna Therapeutics logoMosanna TherapeuticsSeries A$80MJun 2025
    MMosannaSeries A$80MJan 2025
    XII Medical logoXII MedicalSeries B$45MAug 2024
    IIsomabSeed—Feb 2024
    Acesion Pharma logoAcesion PharmaSeries B—Jan 2023
    Nyra Medical, Inc. logoNyra Medical, Inc.Series A$20MNov 2022
    XII Medical logoXII MedicalSeries A$30MMay 2022
    Haya Therapeutics logoHaya TherapeuticsSeed$5MFeb 2022
    CroíValve logoCroíValveSeries A—Jan 2022
    Haya Therapeutics logoHaya TherapeuticsSeed$5MJan 2021
    AAlveron PharmaSeed—Jan 2019
    Renovacor logoRenovacorSeries A$11MJan 2019
    RRenovacorSeries A$11MJan 2019
    Renovacor logoRenovacorSeries A$11MJan 2019
    NIDO Surgical logoNIDO SurgicalSeries A$1.3MFeb 2017
    Acesion Pharma logoAcesion PharmaSeed—Nov 2016
    FINEHEART logoFINEHEARTSeries A—Mar 2016
    AApama MedicalSeries B$11MJan 2015
    InfoBionic, Inc. logoInfoBionic, Inc.Series B$8MJan 2014
    AApama MedicalSeries C$3.2MSep 2013
    AApama MedicalSeries A$3.2MJan 2013
    CCardiAQ Valve TechnologiesSeries B$37.3MDec 2012
    miRagen Therapeutics, Inc. logomiRagen Therapeutics, Inc.Series B$20MApr 2012
    miRagen Therapeutics, Inc. logomiRagen Therapeutics, Inc.Series A$20MJan 2012
    Page 1 of 2

    Top Co-Investors

    Last updated: 20 October 2026